In October 2024, BD and Ypsomed are collaborating to enhance self-injection systems for high-viscosity biologics, aiming to improve patient experience and accessibility for medications requiring complex delivery methods.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.